Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Ruiz

Showing results (241-250 of 254) with videos related to

Pageof 26
Sort By:
Human Molecular Genetics|July 9, 2015
A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosisFuencisla Matesanz, Victor Potenciano, Maria Fedetz, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 12, 2025
Real-world clinical experience with osimertinib in advanced EGFR-mutated non-small cell lung cancerMaría Carmen Areses Manrique, Luis León-Mateos, Sofia Silva-Díaz, et al.
JACC. Cardiovascular Imaging|December 23, 2019
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac AmyloidosisMichele Boldrini, Francesco Cappelli, Liza Chacko, et al.
JACC. Heart Failure|May 1, 2025
The p.Asn271Ile Variant in the TNNT2 Gene Is Associated With Low-Risk Late-Onset Hypertrophic CardiomyopathyJosé M Larrañaga-Moreira, Juan P Ochoa, Rosalía Peteiro-Debén, et al.
Gastroenterology|March 26, 2019
Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated CirrhosisJavier Fernández, Joan Clària, Alex Amorós, et al.
Circulation|August 29, 2025
Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate Effect VariantsSoledad García Hernandez, Luis de la Higuera Romero, Adrián Fernández, et al.
Open Heart|August 5, 2020
Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarctionDaniel Fernández-Bergés, Irene R Degano, Reyes Gonzalez Fernandez, et al.
Therapeutic Advances in Neurological Disorders|December 30, 2025
Real-world effectiveness of horizontal switching between disease-modifying therapies in multiple sclerosis: a retrospective analysis of the MSBase RegistryEnrique Gomez-Figueroa, Patricia Orozco-Puga, Cynthia Patricia Corona-Vázquez, et al.
European Journal of Heart Failure|May 29, 2021
Prevalence and clinical outcomes of dystrophin-associated dilated cardiomyopathy without severe skeletal myopathyMaria A Restrepo-Cordoba, Karim Wahbi, Anca R Florian, et al.
Journal of the American College of Cardiology|August 25, 2022
Natural History of MYH7-Related Dilated CardiomyopathyFernando de Frutos, Juan Pablo Ochoa, Marina Navarro-Peñalver, et al.
Pageof 26

Showing results (241-250 of 254) with videos related to

Sort By:
Pageof 26
Human Molecular Genetics|July 9, 2015
A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosisFuencisla Matesanz, Victor Potenciano, Maria Fedetz, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 12, 2025
Real-world clinical experience with osimertinib in advanced EGFR-mutated non-small cell lung cancerMaría Carmen Areses Manrique, Luis León-Mateos, Sofia Silva-Díaz, et al.
JACC. Cardiovascular Imaging|December 23, 2019
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac AmyloidosisMichele Boldrini, Francesco Cappelli, Liza Chacko, et al.
JACC. Heart Failure|May 1, 2025
The p.Asn271Ile Variant in the TNNT2 Gene Is Associated With Low-Risk Late-Onset Hypertrophic CardiomyopathyJosé M Larrañaga-Moreira, Juan P Ochoa, Rosalía Peteiro-Debén, et al.
Gastroenterology|March 26, 2019
Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated CirrhosisJavier Fernández, Joan Clària, Alex Amorós, et al.
Circulation|August 29, 2025
Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate Effect VariantsSoledad García Hernandez, Luis de la Higuera Romero, Adrián Fernández, et al.
Open Heart|August 5, 2020
Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarctionDaniel Fernández-Bergés, Irene R Degano, Reyes Gonzalez Fernandez, et al.
Therapeutic Advances in Neurological Disorders|December 30, 2025
Real-world effectiveness of horizontal switching between disease-modifying therapies in multiple sclerosis: a retrospective analysis of the MSBase RegistryEnrique Gomez-Figueroa, Patricia Orozco-Puga, Cynthia Patricia Corona-Vázquez, et al.
European Journal of Heart Failure|May 29, 2021
Prevalence and clinical outcomes of dystrophin-associated dilated cardiomyopathy without severe skeletal myopathyMaria A Restrepo-Cordoba, Karim Wahbi, Anca R Florian, et al.
Journal of the American College of Cardiology|August 25, 2022
Natural History of MYH7-Related Dilated CardiomyopathyFernando de Frutos, Juan Pablo Ochoa, Marina Navarro-Peñalver, et al.
Pageof 26